300 Participants Needed

Fear Conditioning Interventions for PTSD

Recruiting at 1 trial location
MM
DM
NN
HM
MM
IM
Overseen ByIsabel Moallem, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this research study is to study how the brain learns to avoid certain stimuli or situations using an experimental paradigm. The big goal is to measure brain responses and subject's feelings and expectations when they are learning to actively avoid experimental stimuli, and how fear extinction learning and monetary cost can change how and when subjects are to avoid.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are using neuroleptics, you must not have taken them within one year prior to the study.

What data supports the effectiveness of the treatment Avoidance conditioning, Fear Conditioning, and related therapies for PTSD?

Research shows that fear conditioning and extinction-based therapies, like exposure therapy, can reduce fear symptoms in PTSD patients, although some may experience a return of fear. Combining these therapies with approach-avoidance training may further reduce fear and prevent its return.12345

Is fear conditioning therapy safe for humans?

The research does not provide specific safety data for fear conditioning therapy, but it is commonly used in exposure therapy for anxiety and PTSD, suggesting it is generally considered safe in clinical settings.13678

How does the fear conditioning treatment for PTSD differ from other treatments?

Fear conditioning treatment for PTSD is unique because it focuses on understanding and modifying the fear learning processes, such as fear extinction and inhibition, which are often impaired in PTSD. This approach uses experimental paradigms to study and potentially improve the way individuals with PTSD respond to fear-related cues, offering a novel method compared to traditional therapies that may not specifically target these underlying fear mechanisms.19101112

Research Team

MM

Mohammed Milad, PhD

Principal Investigator

The University of Texas Health Science Center at Houston (UTHealth Houston)

Eligibility Criteria

This trial is for adults aged 18-70 with current PTSD, diagnosed through specific assessments (CAPS and SCID). It's also open to trauma-exposed healthy controls without any history of psychiatric disorders or PTSD. Participants must be willing to undergo experiments involving avoidance of stimuli.

Inclusion Criteria

I have been diagnosed with PTSD as my primary condition.
I am either female or male.
You are someone who has been diagnosed with PTSD.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Baseline Assessment

Initial assessment visit to establish baseline measures before experimental visits

1 day
1 visit (in-person)

Experimental Visits

Participants undergo an emotional learning paradigm and fMRI scan over two consecutive days

2 days
2 visits (in-person)

Follow-up

Participants are monitored for any delayed responses or effects post-experiment

4 weeks

Treatment Details

Interventions

  • Avoidance conditioning
  • Fear Conditioning
  • Pavlovian fear extinction learning
  • Willingness to pay to avoid shock
Trial Overview The study tests how people with PTSD learn to avoid things that scare them. It involves measuring brain responses and feelings during tasks like paying to avoid shocks, learning about fear, avoiding conditioned stimuli, and overcoming learned fears.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Emotional learning paradigmExperimental Treatment4 Interventions
After the initial screening / baseline assessment visit, participants will undergo two Experimental Visits, which include participation in an emotional learning paradigm and an fMRI scan over the course of two consecutive days. Participants will be asked to look at pictures on a computer screen to measure physiological response physiological response (skin conductance response) and brain responses using a functional Magnetic Resonance Imaging (fMRI) machine. These two visits will be scheduled within a month from the baseline assessment visit.

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

The review highlights various classical conditioning paradigms, such as extinction learning and fear generalization, which are crucial for understanding the development and treatment of PTSD, supported by case examples from patients with severe symptoms.
It discusses the neurobiological mechanisms involved in conditioning and extinction across different populations, suggesting that biological, behavioral, and cognitive factors play significant roles in how PTSD symptoms are learned and treated.
The clinical applications and practical relevance of human conditioning paradigms for posttraumatic stress disorder.Zuj, DV., Norrholm, SD.[2019]
In a study of 110 military personnel and veterans, higher PTSD severity was linked to lower availability of environmental and hedonic rewards, suggesting that individuals with PTSD may struggle to find positive reinforcement in their lives.
The research supports a behavioral economic model of PTSD, indicating that those with the disorder may have a short-sighted focus on immediate rewards rather than future benefits, which could contribute to their symptoms.
The associations between posttraumatic stress disorder and delay discounting, future orientation, and reward availability: A behavioral economic model.Olin, CC., McDevitt-Murphy, ME., Murphy, JG., et al.[2022]
Combining fear extinction therapy with an Approach-Avoidance Task (AAT) did not significantly enhance the reduction of conditioned fear or prevent the return of fear symptoms in participants, suggesting limited effectiveness of this approach.
Despite modifying approach-avoidance tendencies, no significant differences in subjective fear or physiological arousal were observed between groups during follow-up tests, indicating that the addition of AAT may not improve outcomes of traditional exposure therapy.
Effects of Approach-Avoidance Training on the Extinction and Return of Fear Responses.Krypotos, AM., Arnaudova, I., Effting, M., et al.[2018]

References

The clinical applications and practical relevance of human conditioning paradigms for posttraumatic stress disorder. [2019]
The associations between posttraumatic stress disorder and delay discounting, future orientation, and reward availability: A behavioral economic model. [2022]
Effects of Approach-Avoidance Training on the Extinction and Return of Fear Responses. [2018]
An Innovative Framework for Delivering Psychotherapy to Patients With Treatment-Resistant Posttraumatic Stress Disorder: Rationale for Interactive Motion-Assisted Therapy. [2020]
Weaker situations: Uncertainty reveals individual differences in learning: Implications for PTSD. [2023]
Avoidance learning as predictor of posttraumatic stress in firefighters. [2021]
Avoidance learning, Pavlovian conditioning, and the development of phobias. [2019]
Using acceptance and commitment therapy techniques to enhance treatment engagement in veterans with posttraumatic stress disorder. [2021]
Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Behavioral and neural mechanisms of latent inhibition. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Value estimation and latent-state update-related neural activity during fear conditioning predict posttraumatic stress disorder symptom severity. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Extinction learning before trauma and subsequent posttraumatic stress. [2022]